{"id":6652,"date":"2026-10-21T08:17:04","date_gmt":"2026-10-21T02:47:04","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-21\/"},"modified":"2026-10-21T12:25:58","modified_gmt":"2026-10-21T06:55:58","slug":"maxhealth-share-price-today-2026-10-21","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-21\/","title":{"rendered":"Max Healthcare Ins Share Price Today: Why MAXHEALTH Is Falling 0.43% | 21 October 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-witty-phase=\"live\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: MAXHEALTH<\/strong> \u00b7 21 October 2026<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b9826.45<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>-0.43%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b9837.85 \/ \u20b9825.30<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b9830.00<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>8.04 lakh<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>21 October 2026 \u00b7 11:00 AM IST<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-takeaways\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Key Takeaways<\/div>\n<div class=\"wt-card-body\">\n<ul class=\"wt-list\">\n<li>MAX HEALTHCARE INS LTD (MAXHEALTH) is trading down 0.43% at \u20b9826.45, moving within a day&#x27;s range of \u20b9825.30 to \u20b9837.85 after opening slightly higher at \u20b9834.90.<\/li>\n<li>Max Healthcare Institute Limited announced the scrutinizer&#x27;s report and voting results for its postal ballot conducted via remote e-voting from September 20 to October 19, 2026. Members approved the Performance Linked Restricted Stock Unit Scheme 2026, the grant of PRSUs to eligible employees of the company and its subsidiaries, the remuneration payable to Chairman and Managing Director Mr. Abhay Soi, and the alteration of the Main Objects Clause of the Memorandum of Association.<\/li>\n<li>Trading volume was 0.25 times the 20-day average daily volume.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<h2>Why is Max Healthcare Ins share price falling on 21 October 2026?<\/h2>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">MAX HEALTHCARE INS LTD (MAXHEALTH) is trading down 0.43% at \u20b9826.45, moving within a day&#x27;s range of \u20b9825.30 to \u20b9837.85 after opening slightly higher at \u20b9834.90.<\/p>\n<p class=\"wt-copy\">The stock&#x27;s minor dip aligns with a softer tone in the broader healthcare space, as the sectoral benchmark Nifty Pharma declined 0.51%, while the broader Nifty index managed a positive gain of 0.36%. MAXHEALTH&#x27;s move reflects ongoing consolidation after a challenging recent stretch, underscored by a 20-day return of -22.52% and a 5-day return of -4.01%.<\/p>\n<p class=\"wt-copy\">Company disclosures from October 19, 2026, highlighted that shareholders approved the Performance Linked Restricted Stock Unit Scheme 2026 alongside an amendment to the Memorandum of Association during a postal ballot. While these corporate governance updates provide context on long-term capital and incentive structures, they appear to have had a neutral-to-muted direct impact on today&#x27;s minor price adjustment.<\/p>\n<p class=\"wt-copy\">8.04 lakh shares traded by 21 October 2026 \u00b7 11:00 AM IST. This compares with a 20-day average daily volume of 32.50 lakh shares (0.25 times). The five-day average daily volume was 31.28 lakh shares. Separately, the NSE report for 19 October 2026 showed 10.54 lakh shares delivered, representing 51.58% of that day\u2019s traded volume. The same report recorded 48,522 trades.<\/p>\n<\/div>\n<div class=\"wt-likely-reason\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Likely Reason<\/div>\n<div class=\"wt-card-body\"><strong>sector-aligned consolidation amid low volume<\/strong><\/p>\n<p class=\"wt-copy\">The stock&#x27;s modest pullback of 0.43% occurs on thin trading volumes (0.25x of 20-day average volume) alongside a softer Nifty Pharma sector. Recent corporate updates regarding employee incentive schemes and memorandum amendments provide structural context but lack direct intraday catalysts, making the move primarily a reflection of broader sectoral consolidation.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div class=\"wt-grid wt-grid-news\">\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Postal Ballot Voting Results and Scheme Approvals<\/div>\n<div class=\"wt-card-date\">20 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Max Healthcare Institute Limited announced the scrutinizer&#x27;s report and voting results for its postal ballot conducted via remote e-voting from September 20 to October 19, 2026. Members approved the Performance Linked Restricted Stock Unit Scheme 2026, the grant of PRSUs to eligible employees of the company and its subsidiaries, the remuneration payable to Chairman and Managing Director Mr. Abhay Soi, and the alteration of the Main Objects Clause of the Memorandum of Association.<\/p>\n<p class=\"wt-copy\">These approvals establish key long-term incentive frameworks and expand the operational scope of the company&#x27;s business objects.<\/p>\n<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Assignment of Independent ESG Rating<\/div>\n<div class=\"wt-card-date\">16 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">The company received an intimation from NSE Sustainability Ratings and Analytics Limited informing that an independent ESG rating of &#x27;66&#x27; had been assigned for the financial year 2025-26 based on public disclosures. The company clarified that it had not formally engaged the provider for this rating.<\/p>\n<p class=\"wt-copy\">Provides an external benchmark of the company&#x27;s sustainability and governance disclosure standards.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_16102026154317_SE_Intimation_ESG_Rating.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Credit Rating Reaffirmation and Upgrades<\/div>\n<div class=\"wt-card-date\">10 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">CARE Ratings Limited upgraded and reaffirmed credit ratings for material subsidiary Crosslay Remedies Limited across various bank facilities, assigning a CARE AA+; Stable rating. The company also announced a reaffirmation of its own standalone bank credit facilities at CARE AA+; Stable and CARE A1+ on October 9, 2026.<\/p>\n<p class=\"wt-copy\">Reinforces the credit profile and borrowing capacity of both the parent entity and its key subsidiary.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_09102026222417_SE_Intimation.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">General Updates<\/div>\n<div class=\"wt-card-date\">20 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_19102026215500_SE_Disclosure__PRSU_Alteration_of_MOA.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Shareholders meeting<\/div>\n<div class=\"wt-card-date\">20 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Max Healthcare Institute Limited has submitted the Exchange a copy Scrutinizers report of Postal Ballot. Further, the Company has informed the Exchange regarding voting results.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_19102026214552_SE_Disclosure.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid wt-grid-ownership\">\n<div class=\"wt-card\" data-card=\"ownership\" style=\"background:#fff8e8;border:1px solid #ecd39e;border-left:4px solid #cc922c;border-radius:10px\">\n<div class=\"wt-card-title\">Shareholding<\/div>\n<div class=\"wt-card-date\">As of 30 September 2026<\/div>\n<div class=\"wt-card-body\">\n<div class=\"wt-grid wt-grid-metrics\">\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Promoter holding<\/div>\n<div class=\"wt-value\">23.71%<\/div>\n<div class=\"wt-note\">23.71% on 30 June 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">FII\/FPI<\/div>\n<div class=\"wt-value\">40.52%<\/div>\n<div class=\"wt-note\">41.78% on 30 June 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Institutional holding<\/div>\n<div class=\"wt-value\">71.52%<\/div>\n<div class=\"wt-note\">71.74% on 30 June 2026<\/div>\n<\/div>\n<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1740060_16102026044443_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Mutual Fund Holdings<\/h2>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Mutual-fund ownership<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Mutual funds held 19.25% on 30 September 2026. This compares with 18.68% on 30 June 2026, a change of +0.57 percentage points.<\/p>\n<p class=\"wt-copy\">The filing reported 40 MF\/UTI holders.<\/p>\n<div class=\"wt-grid wt-grid-funds\">\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Hdfc Mutual Fund through various schemes<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">3.17 crore shares \u00b7 3.26%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Invesco Mutual Fund through various schemes<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">2.79 crore shares \u00b7 2.87%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">SBI Mutual Fund through various schemes<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">2.52 crore shares \u00b7 2.59%<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-note wt-source-note\">These are quarterly holdings, rather than purchases or sales on the article date.<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1740060_16102026044443_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<h2>What to Watch Next<\/h2>\n<ul class=\"wt-list\">\n<li>Execution and implementation timelines for the newly approved Performance Linked Restricted Stock Unit Scheme 2026<\/li>\n<li>Developments regarding the expansion of business objects under the amended Memorandum of Association<\/li>\n<li>Volume participation relative to the 20-day average volume of approximately 0.25x<\/li>\n<li>Delivery percentage trends following the recent delivery rate of 51.58% recorded on October 19, 2026 across 48,522 trades<\/li>\n<\/ul>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-13\/\">Max Healthcare Ins Share Price Today: Why MAXHEALTH Is Falling 2.81% | 13 October 2026 \u2014 13 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-06\/\">Why MAXHEALTH Shares Fell 1.58% Today: Sector Divergence Explored | 6 October 2026 \u2014 6 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-05\/\">Why Max Healthcare Shares Fell 2.55% Today: Sector Weakness &amp; Pullback | 5 October 2026 \u2014 5 October 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/maxhealth\/\">More Max Healthcare Ins news and dated analysis \u2192<\/a><\/p>\n<aside class=\"wt-cta wt-cta-dark\">\n<div class=\"wt-cta-title\">Looking for Research-Backed Market Opportunities?<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"wt-faq\">\n<h3>What is the latest Max Healthcare Ins company news?<\/h3>\n<p class=\"wt-copy\">Max Healthcare Institute Limited announced the scrutinizer&#x27;s report and voting results for its postal ballot conducted via remote e-voting from September 20 to October 19, 2026. Members approved the Performance Linked Restricted Stock Unit Scheme 2026, the grant of PRSUs to eligible employees of the company and its subsidiaries, the remuneration payable to Chairman and Managing Director Mr. Abhay Soi, and the alteration of the Main Objects Clause of the Memorandum of Association.<\/p>\n<h3>How strong was Max Healthcare Ins\u2019s trading volume?<\/h3>\n<p class=\"wt-copy\">8.04 lakh shares traded, 0.25 times the 20-day average daily volume. The price and volume data are dated 21 October 2026 \u00b7 11:00 AM IST.<\/p>\n<h3>Do the mutual-fund figures show buying today?<\/h3>\n<p class=\"wt-copy\">They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.<\/p>\n<\/div>\n<p><strong>Research &amp; analysis:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><br \/><strong>Reviewed by:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">Mohanish Sanghavi \u2014 SEBI Registered Research Analyst<\/a><\/p>\n<p>Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.<\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-21\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/maxhealth-share-price-today-2026-10-21\/\"}, \"headline\": \"Max Healthcare Ins Share Price Today: Why MAXHEALTH Is Falling 0.43% | 21 October 2026\", \"description\": \"Max Healthcare Ins share price fell 0.43% to \u20b9826.45 today. See why MAXHEALTH is falling, volume context, company developments and what to watch next.\", \"datePublished\": \"2026-10-21T02:47:04Z\", \"dateModified\": \"2026-10-21T12:25:49.680490+05:30\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"reviewedBy\": {\"@type\": \"Person\", \"name\": \"Mohanish Sanghavi\", \"jobTitle\": \"SEBI Registered Research Analyst\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/maxhealth-company-news-2026-10-21.jpg\"]}<\/script><!-- wt-article-record:{\"news_events\":[{\"title\":\"General Updates\",\"summary\":\"disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015\",\"source\":\"NSE\",\"published\":\"19-Oct-2026 21:55:45\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_19102026215500_SE_Disclosure__PRSU_Alteration_of_MOA.pdf\",\"disclosure_text\":\"October 19, 2026 Listing Department, National Stock Exchange of India Limited Exchange Plaza, Plot C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol: MAXHEALTH Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 543220 Sub.: Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir \/ Madam, In continuation to our earlier intimation s dated September 19, 2026 and October 19, 2026 , we wish to inform that, the members of the Company on October 19, 2026, through Postal Ballot by way of remote e-voting have, inter-alia, approved the following: Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026 and grant of Performance Linked Restricted Stock Units to the Eligible Employees of the Company Grant of Performance Linked Restricted Stock Units under the \u2018Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026\u2019 to the Eligible Employees of the Subsidiary Companies Alteration of the Main Objects Clause of the Memorandum of Association of the Company Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in. Kindly take the same on record. Thanking you Yours truly, For Max Healthcare Institute Limited Dhiraj Aroraa EVP - Company Secretary and Compliance Officer Encl.: As above Annexure Details with respect to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 a. Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026 S. No. Particulars Details 1. Whether the scheme is in terms of SEBI (SBEB) Regulations, 2021 Yes 2. Total number of shares covered by these options The total number of Shares that may be issued and allotted pursuant to the Exercise of Performance Linked Restricted Stock Unit (\u201cPRSUs\u201d) under Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026 (\u201cMHIL PRSU Scheme 2026 \u201d) granted under the Scheme shall not exceed 73,50,000 equity shares of the Company of face value \u20b910\/- each, representing ~0.76% of the paid-up equity share capital of the Company as on August 13, 2026. 3. Pricing formula The Exercise Price of each PRSU sha ll be equal to the face value of one Equity Share of the Company prevailing on the Grant Date, which is presently \u20b910\/- per Equity Share. 4. Time within which options may be exercised Exercise Period shall commence on the respective Vesting Date and shall expire upon completion of three years from the date of such Vesting. 5. Brief details of significant terms The significant terms are as per the MHIL PRSU Scheme 2026 available on the Company\u2019s website at www.maxhealthcare.in\/employee-benefit- scheme-documents. Note: Since the MHIL PRSU Scheme 2026 has been approved by the Members of the Company, but no Options have been granted under the Scheme as on date , details such as: brief details of options granted, Options vested, Options exercised, Money realized by exercise of Options, Options lapsed, Total number of shares arising as a result of exercise of options, Variation of Terms of options, subsequent changes or cancellation or exercise of such Options, diluted earnings per share pursuant to issue of equity shares on exercise of options, etc. specified by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are not applicable at this point of time. b. Alteration of the Main Objects Clause of the Memorandum of Association of the Company S. No. Particulars Details 1. Brief details of amendment in Memorandum of Association of the Company Amendment in Clause III. (A) titled \u2018THE MAIN OBJECTS TO BE PURSUED BY THE COMPANY ON ITS INCORPORATION ARE\u2019 of the Memorandum of Association of the Company by inserting the following sub-Clauses 7, 8 and 9 after the existing sub-Clause 6, subject to the approval of Registrar of Companies\/ Ministry of Corporate Affairs: 7. To establish, promote, develop, own, acquire, run, manage and operate medical colleges, medical institutions, teaching institutions and other educational institutions for imparting undergraduate, postgraduate, doctoral and other medical, healthcare and allied health education and training, including education and training in medicine, nursing, pharmacy, physiother apy, rehabilitation, allied health sciences, healthcare administration, hospital management and other related disciplines, including degree, diploma, fellowship and certification programmes, and to establish, develop and operate teaching hospitals, clinical and other facilities and programmes in connection therewith, and to undertake research, skill development, professional training and certification in such fields, subject to applicable laws and the approvals, permissions, recognitions and accreditations of the competent authorities 8. To manufacture, formulate, process, develop, produce, prepare, package, market, distribute, sell, purchase, import, export, supply and otherwise deal in pharmaceuticals, pharmaceutical preparations, formulations, medicines, drugs, medical preparations, enzymes, pharmaceutical intermediates, injectables, radiopharmaceuticals, radioisotopes and other medical, healthcare and allied products, including Fluorodeoxyglucose (FDG) and other radiopharmaceuticals and radioisotopes produced, processed or used through cyclotron, proton and other particle accelerator facilities and technologies, and sanitary, surgical and other medical supplies, and to establish, acquire, install, operate and maintain cyclotron, proton and other particle accelerator facilities and relate d laboratories, equipment and infrastructure for the manufacture, production, processing, research, development and application of such products, and to undertake all research, development and other activities incidental or conducive thereto, subject to applicable laws, licences, registrations, approvals and permissions. S. No. Particulars Details 9. To establish, operate, manage and provide food and beverage and allied services in or in connection with hospitals, medical colleges, medical institutions, healthcare facilities, education al institutions and other establishments of the Company, including cafeterias, canteens, food courts, catering facilities, restaurants, caf\u00e9s, bakeries, confectioneries and other food and beverage establishments, and to undertake the preparation, processin g, manufacture, procurement, packaging, distribution, marketing, sale and supply of food, beverages and allied products and services incidental or conducive thereto, subject to applicable laws.\"},{\"title\":\"Shareholders meeting\",\"summary\":\"Max Healthcare Institute Limited has submitted the Exchange a copy Scrutinizers report of Postal Ballot. Further, the Company has informed the Exchange regarding voting results.\",\"source\":\"NSE\",\"published\":\"19-Oct-2026 21:49:13\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_19102026214552_SE_Disclosure.pdf\",\"disclosure_text\":\"October 19, 2026 Listing Department, National Stock Exchange of India Limited Exchange Plaza, Plot C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol: MAXHEALTH Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 543220 Sub.: Voting Results and Scrutinizer\u2019s Report on Postal Ballot Ref.: Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir \/ Madam, We wish to inform that based on the scrutinizer\u2019s report dated October 19, 2026 on the postal ballot, members of the Company have duly passed the following special resolutions as set out in the postal ballot notice dated August 13, 2026: S. No. Description of Resolution 1. Approval of \u2018Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026\u2019 and grant of Performance Linked Restricted Stock Units to the Eligible Employees of the Company 2. Grant of Performance Linked Restricted Stock Units under the \u2018Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026\u2019 to the Eligible Employees of the Subsidiary Companies 3. Approval of remuneration payable to Mr Abhay Soi as Chairman and Managing Director of the Company 4. Alteration of the Main Objects Clause of the Memorandum of Association of the Company In view of the above, please find enclosed herewith the following documents: Details of voting results in the format specified under regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - A; and Scrutinizer\u2019s report pursuant to section 108 & 110 of the Companies Act, 2013 read with rule 20 & 22 of the Companies (Management and Administration) Rules, 2014 as Annexure - B. The voting results along with the scrutinizer\u2019s report will also be hosted on Company's website viz. www.maxhealthcare.in and website of the E-voting service provider (MUFG Intime India Private Limited) viz. https:\/\/instavote.linkintime.co.in\/. Kindly take the same on record. Thanking you Yours truly, For Max Healthcare Institute Limited Dhiraj Aroraa EVP - Company Secretary and Compliance Officer Encl.: As above Annexure - A Voting Results of Postal Ballot (As per Regulation 44(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015) Particulars Details Name of the Company Max Healthcare Institute Limited Date of Postal Ballot Notice August 13, 2026 Remote E-voting Period September 20, 2026 - October 19, 2026 Date of AGM\/EGM (Postal Ballot) Resolutions passed on October 19, 2026 Cut-off date September 18, 2026 Total number of shareholders as on record date (Cut-off date) 2,28,669 No. of shareholders present in the meeting either in person or through proxy Not Applicable Promoters & Promoter Group Public No. of Members attended the meeting through Video Conferencing: Not Applicable a) Promoters & Promoter Group Public Resolution No. 1 Resolution required: (Ordinary \/ Special) Special Whether promoter\/promoter group are interested in the agenda\/resolution? No Description of resolution considered Approval of \u2018Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026\u2019 and grant of Performance Linked Restricted Stock Units to the Eligible Employees of the Company Category Mode of voting No. of shares held No. of votes polled % of Votes polled on outstanding shares No. of votes in favour No. of votes against % of votes in favour on votes polled % of votes against on votes polled (1) (2) (3) = [(2)\/(1)]*100 (4) (5) (6) = [(4)\/(2)]*100 (7) = [(5)\/(2)]*100 Promoter and Promoter Group E-Voting 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (A) 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Public- Institutions E-Voting 69,75,57,243 64,81,71,275 92.920 63,22,85,266 1,58,86,009 97.549 2.451 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (B) 69,75,57,243 64,81,71,275 92.920 63,22,85,266 1,58,86,009 97.549 2.451 Public - Non- Institutions E-Voting 4,49,75,309 45,37,850 10.090 45,19,905 17,945 99.605 0.395 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (C) 4,49,75,309 45,37,850 10.090 45,19,905 17,945 99.605 0.395 Total (A+B+C) 97,33,10,251 88,34,86,824 90.771 86,75,82,870 1,59,03,954 98.200 1.800 Resolution No. 2 Resolution required: (Ordinary \/ Special) Special Whether promoter\/promoter group are interested in the agenda\/resolution? No Description of resolution considered Grant of Performance Linked Restricted Stock Units under the \u2018Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026\u2019 to the Eligible Employees of the Subsidiary Companies Category Mode of voting No. of shares held No. of votes polled % of Votes polled on outstanding shares No. of votes in favour No. of votes against % of votes in favour on votes polled % of votes against on votes polled (1) (2) (3) = [(2)\/(1)]*100 (4) (5) (6) = [(4)\/(2)]*100 (7) = [(5)\/(2)]*100 Promoter and Promoter Group E-Voting 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (A) 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Public- Institutions E-Voting 69,75,57,243 64,81,71,275 92.920 63,30,68,752 1,51,02,523 97.670 2.330 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (B) 69,75,57,243 64,81,71,275 92.920 63,30,68,752 1,51,02,523 97.670 2.330 Public - Non- Institutions E-Voting 4,49,75,309 45,37,849 10.090 45,19,781 18,068 99.602 0.398 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (C) 4,49,75,309 45,37,849 10.090 45,19,781 18,068 99.602 0.398 Total (A+B+C) 97,33,10,251 88,34,86,823 90.771 86,83,66,232 1,51,20,591 98.289 1.711 Resolution No. 3 Resolution required: (Ordinary \/ Special) Special Whether promoter\/promoter group are interested in the agenda\/resolution? Yes Description of resolution considered Approval of remuneration payable to Mr Abhay Soi as Chairman and Managing Director of the Company Category Mode of voting No. of shares held No. of votes polled % of Votes polled on outstanding shares No. of votes in favour No. of votes against % of votes in favour on votes polled % of votes against on votes polled (1) (2) (3) = [(2)\/(1)]*100 (4) (5) (6) = [(4)\/(2)]*100 (7) = [(5)\/(2)]*100 Promoter and Promoter Group E-Voting 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (A) 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Public- Institutions E-Voting 69,75,57,243 64,78,25,383 92.870 62,27,77,300 2,50,48,083 96.134 3.866 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (B) 69,75,57,243 64,78,25,383 92.870 62,27,77,300 2,50,48,083 96.134 3.866 Public - Non- Institutions E-Voting 4,49,75,309 45,37,956 10.090 45,20,794 17,162 99.622 0.378 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (C) 4,49,75,309 45,37,956 10.090 45,20,794 17,162 99.622 0.378 Total (A+B+C) 97,33,10,251 88,31,41,038 90.736 85,80,75,793 2,50,65,245 97.162 2.838 Resolution No. 4 Resolution required: (Ordinary \/ Special) Special Whether promoter\/promoter group are interested in the agenda\/resolution? No Description of resolution considered Alteration of the Main Objects Clause of the Memorandum of Association of the Company Category Mode of voting No. of shares held No. of votes polled % of Votes polled on outstanding shares No. of votes in favour No. of votes against % of votes in favour on votes polled % of votes against on votes polled (1) (2) (3) = [(2)\/(1)]*100 (4) (5) (6) = [(4)\/(2)]*100 (7) = [(5)\/(2)]*100 Promoter and Promoter Group E-Voting 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (A) 23,07,77,699 23,07,77,699 100.000 23,07,77,699 0 100.000 0.000 Public- Institutions E-Voting 69,75,57,243 64,81,71,275 92.920 64,81,71,275 0 100.000 0.000 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (B) 69,75,57,243 64,81,71,275 92.920 64,81,71,275 0 100.000 0.000 Public - Non- Institutions E-Voting 4,49,75,309 45,34,736 10.080 45,21,860 12,876 99.716 0.284 Poll 0 0.00 0 0 0.00 0.00 Postal Ballot (if applicable) 0 0.00 0 0 0.00 0.00 Sub-total (C) 4,49,75,309 45,34,736 10.083 45,21,860 12,876 99.716 0.284 Total (A+B+C) 97,33,10,251 88,34,83,710 90.771 88,34,70,834 12,876 99.999 0.001 I DPV & ASSOCIATES LLP DPV I COMPANY SECRETARIES, LLPIN: AA y .. a350 Reg. Off: B-285, First Floo r, Green Fields, Sector-43, Faridabad-121010 .Dynamic .Precise .Vigilant E-mail: dev@devassociates.com I devesh@devassociates.com,Tele: 0129 4902641 SCRUTINIZER'S REPORT ON POST AL BALLOT PROCESS (THROUGH REMOTE E-VOTING) To, The Chairman & Managing Director Max Healthcare Institute Limited CIN: L72200MH2001 PLC322854 401. 4th Floor. Man Excellenza. S. V. Road, Vile Parle (West), Mumbai - 400056 Maharashtra, India Sub.: Scrutinizer's Report on Postal Ballot Dear Sir, I, Devesh Kumar Vasisht, Managing Partner of M\/s DPV & Associates LLP, Practicing Company Secretaries (Firm Registration Number: L2021 HR009500) was appointed as Scrutinizer by the Board of Directors of Max Healthcare Institute Limited (\\\"Company\\\") at its meeting held on August 13, 2026 for the purpose of scrutinizing Postal Ballot conducted by way of electronic voting (\\\"remote e-votlng\\\") in a fair and transparent manner, in respect of the resolutions mentioned in the Postal Ballot Notice dated August 13, 2026 issued under the provisions of Section 11 O and 108 of the Companies Act, 2013 (\\\"Act\\\") (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) read with Rule 20 & 22 of the Companies (Management and Administration) Rules, 2014 (as amended from time to time) (\\\"Rules\\\") and read with the General Circulars Nos. 14\/2020 dated April 8, 2020, 17\/2020 dated April 13, 2020, read with other relevant circulars, including latest being General Circular no. 03\/2025 dated September 22, 2025, issued by the Ministry of Corporate Affairs (\\\"MCA\\\"}, (collectively referred to as the \\\"MCA Circulars\\\"}, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (\\\"SEBI Listing Regulations\\\"), Secretarial Standard on General Meetings issued by the Institute of Company Secretaries of India and other applicable laws and regulations (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) in respect of the resolutions as mentioned in the Notice of Postal Ballot dated August 13, 2026. In connection with the above-referred matter, I submit the report as under: 1. As informed by the Company, Notice of Postal Ballot along with explanatory statement and remote e-voting instructions (\\\"Postal Ballot Notice\\\") were sent only through electronic mode to all those members, whose e-mail addresses were registered with the Company or its Registrar to an Issue and Share Transfer Agent ('RTA\\\") or with depository( ies) and whose names appeared in the register of members of the Company and\/or in the register of beneficial owners as maintained by the depositories as on Friday, September 18, 2026 (\\\"cut-off date\\\"). 2. The management of the Company is responsible to ensure the compliance with the requirements of the (i) Act and the Rules thereunder; (ii) MCA Circulars (iii) SEBI Listing Regulations and other applicable provisions related to remote e-voting in respect of the resolutions as contained in the Postal Ballot Notice including its dispatch to members of the Company. llPage DPV & Associates LLP Annexure - B 3. My responsibilities as Scrutinizer are restricted to provide a Scrutinizer's Report of the votes cast in 'Favour' or 'Against' the resolutions contained in the Postal Ballot Notice, based on the report generated from the remote e-voting system provided by MUFG lntime India Private Limited (\\\"MUFG lntime\\\"). 4. The Company has published an advertisement on September 20, 2026 regarding service of Postal Ballot Notice to the members in English language newspaper \\\"Financial Express\\\" (all India editions) and in Marathi language newspaper \\\"Navshakti\\\" (Mumbai edition). 5. The members of the Company holding shares as on cut-off date were entitled to vote on the resolutions as contained in the Postal Ballot Notice and could vote through remote e-vo1ing facility only as per the MCA Circulars. Members were provided with the facility to cast their votes on the designated platform of MUFG lntime at httos:\/\/instavote.linkintime.co.in. 6. The remote e-voting commenced on Sunday, September 20, 2026, 09:00 A.M. (1ST) and ended on Monday, October 19, 2026, 05:00 P.M. (1ST). Further, the remote e-voting process was monitored through the Scrutinizer's secured link provided by MUFG lntime on its designated platform i.e., https:J\/instavote.linkintime.co.in. 7. The remote e-voting was unblocked on October 19, 2026 after 05:00 P.M. (1ST) in the presence of two witnesses i.e. Mr. Mukesh Sharma and Mr. Parveen Kumar, who are not in the employment of the Company and have signed below in conformation of the same: t\\u002d\\u002d\ufffd \ufffd Mukesh Sharma Parveen Kumar 8. Thereafter, the particulars of remote e-voting report generated from designated platform of MUFG lntime have been entered in a separate Register maintained for this purpose and the remote e-voting was reconciled with the register of beneficial owners of the Company as on cut\u00ad off date as maintained by the RT A of the Company. 9. As on cut-Off Date, the fully paid-up share capital of the Company was Rs. 973,31,02,510 (Rupees Nine Hundred Seventy-Three Crore Thirty-One Lakh Two Thousand Five Hundred Ten only) divided into 97,33, 10,251 (Ninety-Seven Crore Thirty-Three Lakh Ten Thousand Two Hundred Fifty -One} equity shares of Rs. 10\/- (Rupees Ten only) each. 10. The result of the remote e-voting in respect of the resolutions contained in the Postal Ballot Notice is as under: Resolution No . 1: Approval of 'Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026' and grant of Performance Linked Restricted Stock Units to the Eligible Employees of the Company Special Resolution Particulars Number of Votes received Percentage of No. of Members Voted No. of E-votes total E-votes Assent 1,448* 86, 7 5,82,870 98.1999 Dissent 119* 1,59,03,954 1.8001 Total 1,562* 88,34,86,824 100 \\\"' Five shareholders have voted partly in favour and partly against the resolution. 21Page DPV & Associates LLP Therefore, the above-mentioned resolution has been approved with requisite majority. Resolution No. 2: Grant of Performance Linked Restricted Stock Units under the 'Max Healthcare Institute Limited - Perfonnance Linked Restricted Stock Unit Scheme 2026' to the Eligible Employees of the Subsidiary Companies Special Resolution Particulars Number of Votes received Percentage of Assent No. of Members Voted No. of E-votes 1,452* 86,83,66,232 total E-votes 98.2885 Dissent 114 * 1,51 ,20,591 1. 7115 Total 1,562.. 88,34,86,823 100 \\\" Four shareholders have voted partly in favour and partly against the resolution. Therefore, the above-mentioned resolution has been approved with requisite majority. Resolution No. 3: Approval of remuneration payable to Mr Abhay Soi as Chairman and Managing Director of the Company Special Resolution Particulars Number of Votes received No. of Members Voted No. of E-votes Percentage of total E-votes Assent Dissent Total 1,368* 201* 1,560\\\" 85,80, 75,793 2,50,65,245 88,31,41,038 \\\" Nine shareholders have voted partly in favour and partly against the resolution. 97.1618 2.8382 100 Therefore, the above-mentioned resolution has been approved with requisite majority Resolution No. 4: Alteration of the Main Objects Clause of the Memorandum of Association of the Company Particulars Assent Dissent Total Special Resolution Number of Votes received No. of Members Voted No. of E-votes 1,520* 40* 1,559* 88,34,70,834 12,876 88,34,83, 710 Percentage total E-votes 99.9985 0.0015 100 * One shareholder has voted partly in favour and partly against the resolution. Therefore, the above-mentioned resolution has been approved with requisite majority. of 11. Based on the aforesaid result, the resolutions mentioned above are deemed to have been passed on October 19, 2026, being the last date of remote e-voting for the Members of the Company. A detailed summary of the remote e-voting in respect of the aforesaid resolutions is attached herewith as Annexure-A. 3IPage DPV & Associates LLP 12. The Register containing the details of remote e-voting relating to Postal Ballot will be handed over to Company Secretary of the Company, for preserving safely after the Chairman considers, approves, and signs the minutes of Postal Ballot. Thanking You, For DPV & Associates LLP Company Secretaries Firm Reg. No.: L2021 HR009500 Peer Review Certificate No. 6189\/2024 \ufffd Devesh Kumar Vasisht Managing Partner CP No.:13700 \/ Mem. No. F8488 UDIN: F008488H001943795 Date: October 19, 2026 Place: Faridabad For Max Healthcare Institute Limited Countersigned by Dhiraj Aroraa EVP - Company Secretary and Compliance Officer (Authorised by the Chairman & Managing Director) Date: October 19, 2026 Place: Gurugram ......... ..,. ........... This part of page is left blank intenti onally*\\\"' ..................... .... 41Page DPV & Associates LLP\"},{\"summary\":\"infusion of funds in Kalinga Hospital Ltd.\",\"category\":\"Acquisition\",\"date\":\"03-Sep-2026 15:29:51\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_03092026152852_SE_Disclosure.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":4}],\"recent_news\":[{\"summary\":\"infusion of funds in Kalinga Hospital Ltd.\",\"category\":\"Acquisition\",\"date\":\"03-Sep-2026 15:29:51\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/MAXHEALTH_03092026152852_SE_Disclosure.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":4}],\"shareholding_snapshot\":{\"promoter_pct\":23.71,\"public_pct\":76.29,\"fii_pct\":40.52,\"dii_pct\":31.0,\"mf_pct\":19.25,\"institutional_pct\":71.52,\"noninst_pct\":4.76,\"mf_scheme_count\":40,\"pledged_shares\":null,\"pledged_pct_of_promoter\":null,\"mf_holders\":[{\"name\":\"Hdfc Mutual Fund through various schemes\",\"shares\":31748955,\"pct\":3.26},{\"name\":\"Invesco Mutual Fund through various schemes\",\"shares\":27893560,\"pct\":2.87},{\"name\":\"SBI Mutual Fund through various schemes\",\"shares\":25174516,\"pct\":2.59},{\"name\":\"ICICI Prudential Mutual Fund through various schemes\",\"shares\":17846455,\"pct\":1.83},{\"name\":\"Nippon India Mutual Fund through various schemes\",\"shares\":14995887,\"pct\":1.54}],\"period\":\"30-SEP-2026\",\"submission_date\":\"16-OCT-2026\",\"source\":\"NSE shareholding pattern XBRL\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1740060_16102026044443_WEB.xml\",\"previous_period\":\"30-JUN-2026\",\"previous_promoter_pct\":23.71,\"previous_fii_pct\":41.78,\"previous_dii_pct\":29.96,\"previous_mf_pct\":18.68,\"previous_institutional_pct\":71.74,\"previous_mf_scheme_count\":42,\"previous_pledged_pct_of_promoter\":null,\"previous_pledged_shares\":null}} --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Max Healthcare Ins share price fell 0.43% to \u20b9826.45 today. See why MAXHEALTH is falling, volume context, company developments and what to watch next.<\/p>\n","protected":false},"author":1,"featured_media":6651,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Max Healthcare Ins Share Price Today: Why MAXHEALTH Is Falling 0.43% | 21 October 2026","_witty_meta_description":"Max Healthcare Ins share price fell 0.43% to \u20b9826.45 today. See why MAXHEALTH is falling, volume context, company developments and what to watch next.","_witty_primary_phrase":"Max Healthcare Ins share price today","_witty_reason_label":"sector-aligned consolidation amid low volume","_witty_reason_confidence":"low","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[31],"class_list":["post-6652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-maxhealth"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/6652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=6652"}],"version-history":[{"count":3,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/6652\/revisions"}],"predecessor-version":[{"id":6888,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/6652\/revisions\/6888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/6651"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=6652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=6652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=6652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}